Cargando…
HER2 as a novel therapeutic target for cervical cancer
Surgery and radiation are the current standard treatments for cervical cancer. However, there is no effective therapy for metastatic or recurrent cases, necessitating the identification of therapeutic targets. In order to create preclinical models for screening potential therapeutic targets, we esta...
Autores principales: | Oh, Doo-Yi, Kim, Seokhwi, Choi, Yoon-La, Cho, Young Jae, Oh, Ensel, Choi, Jung-Joo, Jung, Kyungsoo, Song, Ji-Young, Ahn, Suzie E., Kim, Byoung-Gie, Bae, Duk-Soo, Park, Woong-Yang, Lee, Jeong-Won, Song, Sangyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742172/ https://www.ncbi.nlm.nih.gov/pubmed/26435481 |
Ejemplares similares
-
Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
por: Oh, Doo-Yi, et al.
Publicado: (2017) -
Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer
por: Kim, Yu Jin, et al.
Publicado: (2018) -
Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma
por: Lee, Seung Eun, et al.
Publicado: (2016) -
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer
por: Kim, Hyun-Soo, et al.
Publicado: (2015) -
Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer
por: Song, Taejong, et al.
Publicado: (2017)